Switzerland is the only country in Europe offering treatments with psychedelics, but access remains extremely limited for patients. US support for novel treatments means things could change.
  • SaveTheTuaHawk@lemmy.caEnglish
    9·
    2 days ago

    It would be quite stupid for Europe to keep relying on the FDA for drug approvals, especially since 2024. FDA has been approving drugs for Alzheimer’s disease since 2022 that cost a fortune, cause deaths, and show no benefits for patients. Drugs approved due to corruption help no one.